Clean Science & Technology IPO -  Financial Performance Likely To Sustain - ICICI Direct
An employee holds a flask of chemical solution at a lab. (Photographer:Alex Kraus/ Bloomberg)

Clean Science & Technology IPO - Financial Performance Likely To Sustain - ICICI Direct


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Incorporated in 2003, Clean Science and Technology Ltd. manufactures critical specialty chemicals such as performance chemicals, pharmaceutical intermediates and FMCG chemicals.

The company’s products are used as key starting level materials, as inhibitors, or as additives, by customers, for products sold in regulated markets. Key customers include Bayer AG, SRF Ltd., Gennex Laboratories, Nutriad International NV and Vinati Organics Ltd.

It has two certified production facilities with a combined installed capacity of 29,900 MTPA in India strategically in Kurkumbh (Maharashtra), in close proximity to Jawaharlal Nehru Port Trust.

Click on the attachment to read the full report:

ICICI Direct Clean Science IPO July 6.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.